GSK:NYSE
GlaxoSmithKline
46,50 USD
arrow_downward
-0,01%(-0,0050) 1 d.
46,57 USD
arrow_upward
+0,15% (+0,070)todayPred otvorením trhu
Zavreté: 9. 10., 16:00:03 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre GSK…
Trh. kap.
92,67 mld.
Priem. obj.
3,91 mil.
Objem
81,16 tis.
Dividenda
3,91 %
Štvrťročná dividenda
0,45 USD
Prvý obchodný deň po vyplatení dividendy
13. 8. 2026
Pomer cena/zárobky
14,89
Max. za 52 týž.
61,70 USD
Min. za 52 týž.
42,84 USD
Výnosy na akciu
3,12 USD
Beta
0,25
Akcie v obehu
2,16 mld.
Počet zamestnancov
67 tis.
Trh. kap.
92,67 mld.
Priem. obj.
3,91 mil.
Objem
81,16 tis.
Dividenda
3,91 %
Štvrťročná dividenda
0,45 USD
Prvý obchodný deň po vyplatení dividendy
13. 8. 2026
Pomer cena/zárobky
14,89
Max. za 52 týž.
61,70 USD
Min. za 52 týž.
42,84 USD
Výnosy na akciu
3,12 USD
Beta
0,25
Akcie v obehu
2,16 mld.
Počet zamestnancov
67 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
ad-hoc-news.de
·
pred 35 minútami
GSK stock costs EUR 20.89 with USD 93.2 billion market value
Kalkine Media
·
pred 2 hodinami
Is GSK (LSE:GSK) Shares' Dip After The Nuvalent Deal A Pipeline Story In Focus?
The Pharma Letter
·
pred 2 hodinami
Over $800 million investment from GSK to expand operations in Pennsylvania
Perk Valley Now
·
pred 3 hodinami
GSK investing $800 million to expand in Montgomery County
Profil
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
Informácie o subjekte GlaxoSmithKline
Generálny riaditeľEmma Walmsley | Emma Walmsley
Zamestnanci66,8 tis.
Dátum založenia27. 12. 2000
Hlavné sídlo-
Odvetvie-
Webgsk.com